5-Year Results of an IL-23 Inhibitor in Patients With PsA
Sponsored by AbbVie Medical Affairs + Health Impact
Search for Terms or Answers
Dr. Cush reviews best reasons to go to ACR annually, but also the best way to learn ACR26 content this year.
Obesity, in particular in psoriatic arthritis (PsA) was widely covered at #ACR26. This is from the recognition of the size of the problem.
Genetics seems to be playing an increasingly huge role in autoimmune diseases, and certainly in ILD, and we are only now starting to recognize it.
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.